微波消融术在原发性肝癌应用的研究进展
Research Progress of Microwave Ablation in Primary Liver Cancer
DOI: 10.12677/ACM.2022.123342, PDF,   
作者: 朱亚妮：延安大学，陕西 延安 ；刘 斌：延安大学附属医院，陕西 延安
关键词: 原发性肝癌；肝癌；微波消融；局部治疗；热消融；Primary Liver Cancer； Liver Cancer； Microwave Ablation； Local Treatment； Thermal Ablation
摘要: 微波消融术自1994年首次应用于肝癌治疗后，随着微创理念的发展，微波消融术快速发展，凭借其操作简单、疗效佳、创伤小、并发症少，迅速在国内广泛应用于小肝癌的治疗以及部分大肝癌的治疗。现就原发性肝癌微波消融技术的应用发展、影像引导技术的发展、微波消融较其他治疗方式的联合治疗、并发症情况进行综述。
Abstract: Since microwave ablation was first applied in the treatment of liver cancer in 1994, with the development of minimally invasive concept, microwave ablation has developed rapidly. With its simple operation, good efficacy, small trauma and few complications, it is quickly widely used in the treatment of small liver cancer and the treatment of some large liver cancer in China. The application and development of the microwave ablation technology of the primary liver cancer, the development of the image guidance technology, the combined treatment of the microwave ablation and other treatment methods are reviewed.
文章引用：朱亚妮, 刘斌. 微波消融术在原发性肝癌应用的研究进展[J]. 临床医学进展, 2022, 12(3): 2371-2378. https://doi.org/10.12677/ACM.2022.123342

参考文献

[1] Lucchina, N., Tsetis, D., Ierardi, A.M., Giorlando, F., Macchi, E., Kehagias, E., et al. (2016) Current Role of Microwave Ablation in the Treatment of Small Hepatocellular Carcinomas. Annals of Gastroenterology, 29, 1-6. [Google Scholar] [CrossRef] [PubMed]
[2] 刘洪波. 微波消融与手术切除治疗原发性肝癌对患者无瘤生存率、复发率的影响比较[J]. 四川解剖学杂志, 2018, 26(1): 18-20.
[3] 塔来提·吐尔干, 吐尔干艾力·阿吉. 肝癌局部消融治疗引起的热休克蛋白70增强免疫研究进展[J]. 临床肝胆病杂志, 2018, 34(11): 2438-2442.
[4] Abdelaziz, A.O., Nabeel, M.M., Elbaz, T.M., Shousha, H.I., Hassan, E.M., Mahmoud, S.H., et al. (2015) Microwave Ablation versus Transarterial Chemoembolization in Large Hepatocellular Carcinoma: Prospective Analysis. Scandinavian Journal of Gastroenterology, 50, 479-484. [Google Scholar] [CrossRef] [PubMed]
[5] 翟博. 肝脏肿瘤局部消融治疗学[M]. 上海: 第二军医大学出版社, 2017: 329-330.
[6] 刘金伟. 微波消融与手术再切除治疗复发性肝癌的临床对比[J]. 现代医用影像学, 2017, 26(2): 422-423.
[7] 高楠, 牟培源, 白媛媛, 黄雪梅, 姜婷婷. 腹腔镜超声与经皮超声引导微波消融治疗复发性肝癌的临床效果比较[J]. 中国临床新医学, 2021, 14(3): 275-278.
[8] 陈嵩, 庄文权, 郭文波, 吴志强. CT联合超声引导下经皮微波消融治疗尾状叶肝癌的可行性及短期疗效观察[J]. 影像诊断与介入放射学, 2018, 27(3): 219-225.
[9] 陈建, 金霞, 陈晓, 颜朝晖, 张卫兵, 李萍, 等. 人工腹水对膈面、脏面原发性肝癌微波消融治疗中的应用价值[J]. 实用临床医药杂志, 2019, 23(6): 7-12.
[10] 王剑宇, 徐浩, 许伟, 王勇, 柳昂. TACE术后超声引导下经皮无水乙醇注射术联合微波消融治疗特殊部位肝癌[J]. 中国介入影像与治疗学, 2019, 16(4): 203-206.
[11] 葛乃建, 黄剑, 杨业发, 申淑群, 于晓河, 朱俊军, 等. 经皮胆管穿刺引流与经内镜鼻胆管引流胆管冷却保护技术在肝癌微波消融中的应用对比[J]. 介入放射学杂志, 2018, 27(1): 35-39.
[12] 王俊东, 魏达友, 吴绍锋, 刘长珠, 冯清华, 李宝金, 等. 超声新技术辅助特殊部位小肝癌微波消融与手术切除的疗效对比研究[J]. 中国超声医学杂志, 2019, 35(6): 506-510.
[13] 王曦, 程朋, 何芬, 邓旦, 李东. 超声造影引导下微波消融在常规超声显示困难小肝癌中的应用[J]. 临床肝胆病杂志, 2018, 34(8): 1697-1701.
[14] 王俊东, 刘长珠, 李宝金, 刘伟峰, 欧阳维富. 超声造影联合影像融合导航技术在特殊部位小肝癌微波消融治疗中的价值[J]. 中国中西医结合影像学杂志, 2018, 16(4): 394-396+400.
[15] 朱玉鹏, 张德智, 祝英乔. 基于磁定位导航的影像融合联合针尖追踪技术引导微波消融治疗肝脏肿瘤1例[J]. 中国介入影像与治疗学, 2018, 15(1): 63-64.
[16] 王卫兵, 卢朝德, 毛毳. 腹腔镜下微波消融治疗肝癌的疗效及并发症分析[J]. 实用临床医药杂志, 2019, 23(22): 11-13.
[17] 刘东. 经动脉导管灌注化疗栓塞术联合微波消融术治疗对肝癌血清标志物的影响[J]. 贵州医药, 2018, 42(5): 567-568.
[18] 张流, 王军, 熊华刚. 肝癌微波消融术前经肝动脉灌注介入治疗的临床效果及对肝癌患者FHIT、P16蛋白表达的影响[J]. 中国中西医结合消化杂志, 2019, 27(1): 11-15.
[19] 郭江, 李洪璐, 李常青. TACE联合微波消融治疗中晚期肝癌的临床疗效分析[J]. 川北医学院学报, 2019, 34(2): 219-222.
[20] 孙晓, 徐恩松, 邱春玉, 董阳. 微波消融术联合索拉非尼治疗原发性肝癌的效果观察[J]. 实用癌症杂志, 2018, 33(4): 664-667.
[21] Bruix, J., Takayama, T., Mazzaferro, V., Chau, G.Y., Yang, J., Kudo, M., et al. (2015) Adjuvant Sorafenib for Hepatocellular Carcinoma after Resection or Ablation (STORM). The Lancet Oncology, 16, 1344-1354. [Google Scholar] [CrossRef] 
[22] 柏涛, 龚凤云, 胡旭东, 王娟, 夏冰, 程海林, 甘丽娟. 超声引导下经皮微波消融治疗原发性肝癌患者疗效分析[J]. 实用肝脏病杂志, 2018, 21(1): 84-87.
[23] 王新亭, 张传雷, 陈晓琦, 陈欣菊. 胸腺肽α1对肝细胞癌患者热消融术后免疫功能及预后的影响[J]. 现代肿瘤医学, 2018, 26(9): 1388-1391.
[24] 王萍辉. 超声空化影响因素[J]. 河北理工学院学报, 2003, 25(4): 154-161.
[25] Gao, Y., Gao, S., Zhao, B., Zhao, Y., Hua, X., Tan, K., et al. (2012) Vascular Effects of Microbubble—Enhanced, Pulsed, Focused Ultrasound on Liver Blood Perfusion. Ultrasound in Medicine & Biology, 38, 91-98. [Google Scholar] [CrossRef] [PubMed]
[26] 石颖, 张俊旺, 谷芬, 贺建国, 周晓东. 微泡诱导超声空化联合凝血酶增强的微波热消融治疗兔VX2肝癌的转归及生物学效应[J]. 中华超声影像学杂志, 2018, 27(11): 1000-1004.
[27] Liang, P., Wang, Y., Yu, X. and Dong, B. (251) Malignant Liver Tumors Treatment with Percutaneous Microwave Ablation Complications among Cohort of 1136 Patients. Radiology, 251, 933-940. [Google Scholar] [CrossRef] [PubMed]
[28] 邵雪晴, 赵洁琼, 盛月红. 肝癌微波消融术中并发迷走神经反射的抢救及护理[J]. 海军医学杂志, 2014, 35(5): 404-406.
[29] Kawasaki, T., Kudo, M., Chung, H. and Minami, Y. (2004) Hepatocellular Carcinoma That Ruptured during Radiofrequency Ablation Therapy. Journal of Gastroenterology, 39, 1015-1016. [Google Scholar] [CrossRef] [PubMed]
[30] Chiang, J., Birla, S., Bedoya, M., Jones, D., Subbiah, J. and Brace, C.L. (2015) Modeling and Validation of Microwave Ablations with Internal Vaporization. IEEE Transactions on Biomedical Engineering, 62, 657-663. [Google Scholar] [CrossRef] 
[31] Andreano, A., Galimberti, S., Franza, E., et al. (2014) Percutaneous Microwave Ablation of Hepatic Tumors Prospective Evaluation of Postablation Syndrome and Postprocedural Pain. Journal of Vascular and Interventional Radiology, 25, 97-105.E2. [Google Scholar] [CrossRef] [PubMed]
[32] 王丽森, 余辉. 肝癌微波消融术后出血因素分析和预防[J]. 临床研究, 2018, 26(1): 88-90.
[33] 王延明, 王能, 许赟, 沈强, 钱国军. 微波消融治疗7403例肝癌的严重并发症[J]. 中华肝胆外科杂志, 2016, 22(10): 655-660.
[34] Li, H., Li, B., Wei, Y. and Liu, F. (2011) Hemolysis as a Complications of Radiofrequency Ablation for Hepatocellular Carcinoma Must Be Paid More Attention. Digestive Diseases and Sciences, 56, Article No. 3391. [Google Scholar] [CrossRef] [PubMed]
[35] 孙爱学, 钱国军, 盛月红, 屈秀娟, 胡鹏, 张少君. 伴肾功能不全的肝脏恶性肿瘤行消融治疗的临床观察[J]. 中国微创外科杂志, 2013, 13(7): 653-655.
[36] Kong, J., Kong, J., Pan, B., Ke, S., Dong, S., Li, X., et al. (2012) Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1a/VEGFA. PLoS ONE, 7, e37266. [Google Scholar] [CrossRef] [PubMed]
[37] Hu, J., Che, L., Li, L., Pilo, M.G., Cigliano, A., Ribback, S., Li, X., et al. (2016) Co-Activation of AKT and c-Met Triggers Rapid Hepatocellular Carcinoma Development via the mTORC1/FASN Pathway in Mice. Scientific Reports, 6, Article No. 20484. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, C., Cigliano, A., Jiang, L., Li, X., Fan, B., Pilo, M.G., et al. (2015) 4EBP1 eIF4E and p70S6K RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-Oncogenes in Mice. Hepatology, 61, 200-213. [Google Scholar] [CrossRef] [PubMed]
[39] 高君, 柯山, 丁雪梅, 孙文兵. 肝癌重复射频消融术后严重肝损伤四例[J]. 中华肿瘤杂志, 2011, 33(3): 239-240.
[40] Lucchina, N., Tsetis, D., Ierardi, A.M., Giorlando, F., Macchi, E., Kehagias, E., et al. (2016) Current Role of Microwave Ablation in the Treatment of Small Hepatocellular Carcinomas. Annals of Gastroenterology, 29, 1-6. [Google Scholar] [CrossRef] [PubMed]
[41] 刘洪波. 微波消融与手术切除治疗原发性肝癌对患者无瘤生存率、复发率的影响比较[J]. 四川解剖学杂志, 2018, 26(1): 18-20.
[42] 塔来提·吐尔干, 吐尔干艾力·阿吉. 肝癌局部消融治疗引起的热休克蛋白70增强免疫研究进展[J]. 临床肝胆病杂志, 2018, 34(11): 2438-2442.
[43] Abdelaziz, A.O., Nabeel, M.M., Elbaz, T.M., Shousha, H.I., Hassan, E.M., Mahmoud, S.H., et al. (2015) Microwave Ablation versus Transarterial Chemoembolization in Large Hepatocellular Carcinoma: Prospective Analysis. Scandinavian Journal of Gastroenterology, 50, 479-484. [Google Scholar] [CrossRef] [PubMed]
[44] 翟博. 肝脏肿瘤局部消融治疗学[M]. 上海: 第二军医大学出版社, 2017: 329-330.
[45] 刘金伟. 微波消融与手术再切除治疗复发性肝癌的临床对比[J]. 现代医用影像学, 2017, 26(2): 422-423.
[46] 高楠, 牟培源, 白媛媛, 黄雪梅, 姜婷婷. 腹腔镜超声与经皮超声引导微波消融治疗复发性肝癌的临床效果比较[J]. 中国临床新医学, 2021, 14(3): 275-278.
[47] 陈嵩, 庄文权, 郭文波, 吴志强. CT联合超声引导下经皮微波消融治疗尾状叶肝癌的可行性及短期疗效观察[J]. 影像诊断与介入放射学, 2018, 27(3): 219-225.
[48] 陈建, 金霞, 陈晓, 颜朝晖, 张卫兵, 李萍, 等. 人工腹水对膈面、脏面原发性肝癌微波消融治疗中的应用价值[J]. 实用临床医药杂志, 2019, 23(6): 7-12.
[49] 王剑宇, 徐浩, 许伟, 王勇, 柳昂. TACE术后超声引导下经皮无水乙醇注射术联合微波消融治疗特殊部位肝癌[J]. 中国介入影像与治疗学, 2019, 16(4): 203-206.
[50] 葛乃建, 黄剑, 杨业发, 申淑群, 于晓河, 朱俊军, 等. 经皮胆管穿刺引流与经内镜鼻胆管引流胆管冷却保护技术在肝癌微波消融中的应用对比[J]. 介入放射学杂志, 2018, 27(1): 35-39.
[51] 王俊东, 魏达友, 吴绍锋, 刘长珠, 冯清华, 李宝金, 等. 超声新技术辅助特殊部位小肝癌微波消融与手术切除的疗效对比研究[J]. 中国超声医学杂志, 2019, 35(6): 506-510.
[52] 王曦, 程朋, 何芬, 邓旦, 李东. 超声造影引导下微波消融在常规超声显示困难小肝癌中的应用[J]. 临床肝胆病杂志, 2018, 34(8): 1697-1701.
[53] 王俊东, 刘长珠, 李宝金, 刘伟峰, 欧阳维富. 超声造影联合影像融合导航技术在特殊部位小肝癌微波消融治疗中的价值[J]. 中国中西医结合影像学杂志, 2018, 16(4): 394-396+400.
[54] 朱玉鹏, 张德智, 祝英乔. 基于磁定位导航的影像融合联合针尖追踪技术引导微波消融治疗肝脏肿瘤1例[J]. 中国介入影像与治疗学, 2018, 15(1): 63-64.
[55] 王卫兵, 卢朝德, 毛毳. 腹腔镜下微波消融治疗肝癌的疗效及并发症分析[J]. 实用临床医药杂志, 2019, 23(22): 11-13.
[56] 刘东. 经动脉导管灌注化疗栓塞术联合微波消融术治疗对肝癌血清标志物的影响[J]. 贵州医药, 2018, 42(5): 567-568.
[57] 张流, 王军, 熊华刚. 肝癌微波消融术前经肝动脉灌注介入治疗的临床效果及对肝癌患者FHIT、P16蛋白表达的影响[J]. 中国中西医结合消化杂志, 2019, 27(1): 11-15.
[58] 郭江, 李洪璐, 李常青. TACE联合微波消融治疗中晚期肝癌的临床疗效分析[J]. 川北医学院学报, 2019, 34(2): 219-222.
[59] 孙晓, 徐恩松, 邱春玉, 董阳. 微波消融术联合索拉非尼治疗原发性肝癌的效果观察[J]. 实用癌症杂志, 2018, 33(4): 664-667.
[60] Bruix, J., Takayama, T., Mazzaferro, V., Chau, G.Y., Yang, J., Kudo, M., et al. (2015) Adjuvant Sorafenib for Hepatocellular Carcinoma after Resection or Ablation (STORM). The Lancet Oncology, 16, 1344-1354. [Google Scholar] [CrossRef] 
[61] 柏涛, 龚凤云, 胡旭东, 王娟, 夏冰, 程海林, 甘丽娟. 超声引导下经皮微波消融治疗原发性肝癌患者疗效分析[J]. 实用肝脏病杂志, 2018, 21(1): 84-87.
[62] 王新亭, 张传雷, 陈晓琦, 陈欣菊. 胸腺肽α1对肝细胞癌患者热消融术后免疫功能及预后的影响[J]. 现代肿瘤医学, 2018, 26(9): 1388-1391.
[63] 王萍辉. 超声空化影响因素[J]. 河北理工学院学报, 2003, 25(4): 154-161.
[64] Gao, Y., Gao, S., Zhao, B., Zhao, Y., Hua, X., Tan, K., et al. (2012) Vascular Effects of Microbubble—Enhanced, Pulsed, Focused Ultrasound on Liver Blood Perfusion. Ultrasound in Medicine & Biology, 38, 91-98. [Google Scholar] [CrossRef] [PubMed]
[65] 石颖, 张俊旺, 谷芬, 贺建国, 周晓东. 微泡诱导超声空化联合凝血酶增强的微波热消融治疗兔VX2肝癌的转归及生物学效应[J]. 中华超声影像学杂志, 2018, 27(11): 1000-1004.
[66] Liang, P., Wang, Y., Yu, X. and Dong, B. (251) Malignant Liver Tumors Treatment with Percutaneous Microwave Ablation Complications among Cohort of 1136 Patients. Radiology, 251, 933-940. [Google Scholar] [CrossRef] [PubMed]
[67] 邵雪晴, 赵洁琼, 盛月红. 肝癌微波消融术中并发迷走神经反射的抢救及护理[J]. 海军医学杂志, 2014, 35(5): 404-406.
[68] Kawasaki, T., Kudo, M., Chung, H. and Minami, Y. (2004) Hepatocellular Carcinoma That Ruptured during Radiofrequency Ablation Therapy. Journal of Gastroenterology, 39, 1015-1016. [Google Scholar] [CrossRef] [PubMed]
[69] Chiang, J., Birla, S., Bedoya, M., Jones, D., Subbiah, J. and Brace, C.L. (2015) Modeling and Validation of Microwave Ablations with Internal Vaporization. IEEE Transactions on Biomedical Engineering, 62, 657-663. [Google Scholar] [CrossRef] 
[70] Andreano, A., Galimberti, S., Franza, E., et al. (2014) Percutaneous Microwave Ablation of Hepatic Tumors Prospective Evaluation of Postablation Syndrome and Postprocedural Pain. Journal of Vascular and Interventional Radiology, 25, 97-105.E2. [Google Scholar] [CrossRef] [PubMed]
[71] 王丽森, 余辉. 肝癌微波消融术后出血因素分析和预防[J]. 临床研究, 2018, 26(1): 88-90.
[72] 王延明, 王能, 许赟, 沈强, 钱国军. 微波消融治疗7403例肝癌的严重并发症[J]. 中华肝胆外科杂志, 2016, 22(10): 655-660.
[73] Li, H., Li, B., Wei, Y. and Liu, F. (2011) Hemolysis as a Complications of Radiofrequency Ablation for Hepatocellular Carcinoma Must Be Paid More Attention. Digestive Diseases and Sciences, 56, Article No. 3391. [Google Scholar] [CrossRef] [PubMed]
[74] 孙爱学, 钱国军, 盛月红, 屈秀娟, 胡鹏, 张少君. 伴肾功能不全的肝脏恶性肿瘤行消融治疗的临床观察[J]. 中国微创外科杂志, 2013, 13(7): 653-655.
[75] Kong, J., Kong, J., Pan, B., Ke, S., Dong, S., Li, X., et al. (2012) Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1a/VEGFA. PLoS ONE, 7, e37266. [Google Scholar] [CrossRef] [PubMed]
[76] Hu, J., Che, L., Li, L., Pilo, M.G., Cigliano, A., Ribback, S., Li, X., et al. (2016) Co-Activation of AKT and c-Met Triggers Rapid Hepatocellular Carcinoma Development via the mTORC1/FASN Pathway in Mice. Scientific Reports, 6, Article No. 20484. [Google Scholar] [CrossRef] [PubMed]
[77] Wang, C., Cigliano, A., Jiang, L., Li, X., Fan, B., Pilo, M.G., et al. (2015) 4EBP1 eIF4E and p70S6K RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-Oncogenes in Mice. Hepatology, 61, 200-213. [Google Scholar] [CrossRef] [PubMed]
[78] 高君, 柯山, 丁雪梅, 孙文兵. 肝癌重复射频消融术后严重肝损伤四例[J]. 中华肿瘤杂志, 2011, 33(3): 239-240.

为你推荐